Drug Name: | Orphenadrine (83-98-7) |
---|---|
PubChem ID: | 4601 |
SMILES: | CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C |
InchiKey: | QVYRGXJJSLMXQH-UHFFFAOYSA-N |
Therapeutic Category: | Anti-Dyskinesia Agents, Antiparkinson Agents, Autonomic Agents, Central Nervous System Agents, Cholinergic Agents, Cholinergic Antagonists, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Enzyme Inhibitors, Muscarinic Antagonists, Muscle Relaxants, Neuromuscular Agents, Neurotransmitter Agents, Parasympatholytics, Peripheral Nervous System Agents |
Molecular Weight (dalton) | : | 269.388 |
LogP | : | 3.66262 |
Ring Count | : | 2 |
Hydrogen Bond Acceptor Count | : | 2 |
Hydrogen Bond Donor Count | : | 0 |
Total Polar Surface Area | : | 12.47 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Propoxyphene (469-62-5) | Tremors | Antagonistic | Not Understood | Drug interaction? Orphenadrine with propoxyphene |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category